Invention Grant
US08426180B2 Use of carbamoyl phosphate synthetase 1 (CPS) as a humoral biomarker for the diagnosis of tumour diseases and chronic inflammatory intestinal diseases
有权
氨基甲酰磷酸合成酶1（CPS）作为体液生物标志物用于诊断肿瘤疾病和慢性炎症性肠病
- Patent Title: Use of carbamoyl phosphate synthetase 1 (CPS) as a humoral biomarker for the diagnosis of tumour diseases and chronic inflammatory intestinal diseases
- Patent Title (中): 氨基甲酰磷酸合成酶1（CPS）作为体液生物标志物用于诊断肿瘤疾病和慢性炎症性肠病
-
Application No.: US12986385Application Date: 2011-01-07
-
Publication No.: US08426180B2Publication Date: 2013-04-23
- Inventor: Andreas Bergmann , Joachim Struck
- Applicant: Andreas Bergmann , Joachim Struck
- Applicant Address: DE Henningsdorf
- Assignee: B.R.A.H.M.S GmbH
- Current Assignee: B.R.A.H.M.S GmbH
- Current Assignee Address: DE Henningsdorf
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- Priority: DE102004045705 20040921
- Main IPC: C12Q1/00
- IPC: C12Q1/00 ; C12P21/06 ; G01N33/53 ; G01N33/563
Abstract:
The invention relates to the use of carbamoyl synthetase 1 (CPS 1) as a humoral biomarker in in vitro methods for early diagnosis and detection, progress prognosis, the evaluation of the severity, and the progress evaluation of tumor diseases and chronic inflammatory intestinal diseases.
Public/Granted literature
Information query
